ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment

Cheng, Bisheng; Li, Lingfeng; Wu, Yongxin; Luo, Tianlong; Tang, Chen; Wang, Qiong; Zhou, Qianghua; Wu, Jilin; Lai, Yiming; Zhu, Dingjun*; Du, Tao; Huang, Hai*广州医学院; 南方医科大学; 中山大学; 6
Cell and Bioscience2023-11-15DOI: 10.1186/s13578-023-01157-6
1被引8阅读
引用收藏
分享

摘要

BackgroundProstate cancer is a leading cause of cancer-related deaths among men worldwide. Docetaxel chemotherapy has proven effective in improving overall survival in patients with castration-resistant prostate cancer (CRPC), but drug resistance remains a considerable clinical challenge.MethodsWe explored the role of Ribonucleotide reductase subunit M2 (RRM2), a gene associated with senescence, in the sensitivity of prostate cancer to docetaxel. We evaluated the RRM2 expression, docetaxel resistance, and ANXA1 expression in prostate cancer cell lines and tumour xenografts models. In addition, We assessed the impact of RRM2 knockdown, ANXA1 over-expression, and PI3K/AKT pathway inhibition on the sensitivity of prostate cancer cells to docetaxel. Furthermore, we assessed the sensitivity of prostate cancer cells to the combination treatment of COH29 and docetaxel.ResultsOur results demonstrated a positive association between RRM2 expression and docetaxel resistance in prostate cancer cell lines and tumor xenograft models. Knockdown of RRM2 increased the sensitivity of prostate cancer cells to docetaxel, suggesting its role in mediating resistance. Furthermore, we observed that RRM2 stabilizes the expression of ANXA1, which in turn activates the PI3K/AKT pathway and contributes to docetaxel resistance. Importantly, we found that the combination treatment of COH29 and docetaxel resulted in a synergistic effect, further augmenting the sensitivity of prostate cancer cells to docetaxel.ConclusionOur findings suggest that RRM2 regulates docetaxel resistance in prostate cancer by stabilizing ANXA1-mediated activation of the PI3K/AKT pathway. Targeting RRM2 or ANXA1 may offer a promising therapeutic strategy to overcome docetaxel resistance in prostate cancer.

学科与关键词

关键词
RRM2Prostate cancerChemotherapyDocetaxelOncology
相关
加载中…
  • CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer
    Chen, Binshen; Zhang, Yiming; Li, Chaoming; Xu, Peng; Gao, Yubo; Xu, Yawen*Archives of Medical Science, 2021, 17(1): 152-165.被引 16
  • AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer
    Fu, Yongming; Cao, Tuoyu; Zou, Xiaorui; Ye, Yubing; Liu, Youhong; Peng, Yuchong; Deng, Tanggang; Yin, Linglong; Li, Xiong*Oncogenesis, 2023, 12(1): 1.被引 4
  • Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response
    Yan Judy; Tang Damu*Experimental Cell Research, 2014, 328(1): 132-142.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell and Bioscience
发表日期
2023-11-15
卷期
第 13 卷, 第 1 期
页码
211
DOI
10.1186/s13578-023-01157-6
语言
ENGLISH
成果收录
SCIE
资助标注
We sincerely thank Prof. Xiaojuan Wang and Tian Qiao from the Bioinformatics and Omics Center at Sun Yat-sen Memorial Hospital for their assistance in mass spectrometry analysis.

作者

  • C

    Cheng, Bisheng (第一作者)

    sun yat sen univ

  • L

    Li, Lingfeng

    sun yat sen univ

查看全部 12 位作者收起作者
  • W

    Wu, Yongxin

    sun yat sen univ

  • L

    Luo, Tianlong

    sun yat sen univ

  • T

    Tang, Chen

    sun yat sen univ

  • W

    Wang, Qiong

    southern med univ

  • Z

    Zhou, Qianghua

    sun yat sen univ

  • W

    Wu, Jilin

    sun yat sen univ

  • L

    Lai, Yiming

    sun yat sen univ

  • Z

    Zhu, Dingjun (通讯)

    sun yat sen univ

  • D

    Du, Tao

    sun yat sen univ

  • H

    Huang, Hai (通讯)

    sun yat sen univ · 6 · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417